Breast cancer survivor offers wisdom at Faulkner satellite center
Call 877-422-3324 today to make an appointment
Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.
Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.
Toll-Free Number866-408-DFCI (3324)
Discover the ways to give and how to get involved to support Dana-Farber.
Poet Richard Fox gains insight – and material – through cancer treatment
A family faces cancer in an unfamiliar city – with help
Choosing mastectomy or not: Studying young women's surgical choices
Jeff's targeted therapy has kept his advanced lung cancer at bay.
Building on its historic fundraising telecasts in 2008 and 2010, Stand Up To Cancer (SU2C) will return to primetime television on Friday, September 7 (8:00 pm, ET). The program, which will feature performances from top recording artists, and celebrities from film, television and sports, will encourage viewers to provide financial support for translational research aimed at accelerating the delivery of new cancer therapies to patients.
ABC, CBS, FOX and NBC are donating one hour of simultaneous commercial-free primetime for the nationally televised fundraising special. A number of cable outlets will air the program as well.
This year's program is expected to include a taped segment featuring Avalanna Routh, a Dana-Farber/Children's Hospital Cancer Center patient who is being treated for atypical teratoid rhabdoid tumor (ATRT), her doctor, Susan Chi, MD, and Charles Roberts, MD, PhD, whose laboratory is researching ATRT. Roberts also is one of five Dana-Farber affiliated researchers whose work is being supported with a SU2C Innovative Research Grant, which provides each recipient with up to $750,000 of funding over three years. The other Dana-Farber investigators are Catherine Wu, MD, Kimberly Stegmaier, MD, Loren Walensky, MD, PhD, and David Weinstock, MD.
"Stand Up To Cancer demonstrates the power of the entertainment community to help unite the public in support of a crucial cause that affects us all," said SU2C Executive Leadership Council Member Sherry Lansing, who is also the board chair of the Entertainment Industry Foundation, which helped found SU2C and is producing the broadcast program.
To date, more than $180 million has been pledged for SU2C's innovative cancer research. Since 2008, SU2C has made grants to seven multi-disciplinary "Dream Teams" of researchers, which include 14 Dana-Farber clinicians and researchers:
Philip Kantoff, MDLevi Garraway, MD, PhD
Thomas Roberts, PhDJ. Dirk Iglehart, MDDavid Livingston, MDUrsula Matulonis, MDAndrea Richardson, MD, PhDEric Winer, MD
Bruce Johnson, MDCharles Fuchs, MDJudy Garber, MDWilliam Hahn, MD, PhDPasi Jänne, MD, PhDIan Krop, MD, PhD